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ALI = acute lung injury; ARDS = acute respiratory distress syndrome; ARF = acute respiratory failure; ICU = intensive care unit; FiO2 = fractional
inspired oxygen; PaO2 = arterial oxygen tension; SOFA = Sequential Organ Failure Assessment.
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Introduction
For the intensivist with an interest in epidemiology, the recent
report from Flaatten and coworkers [1], published in this
issue of Critical Care, may serve as a focal point that
highlights several interesting features of that special field.
These include but are not limited to incidence figures and
mortality rates for acute respiratory failure (ARF), the
contribution of additional single organ failures or multiple
organ dysfunction syndrome to mortality, the difficulties of
comparing results of epidemiological studies, and chances
missed to address urgent questions. In this commentary I
highlight these and thereby, hopefully, enhance our
understanding of the often complex associations that
epidemiologists and readers of epidemiological articles will
encounter from time to time.
First, however, I summarize the main findings of the report
under discussion. In a 30-month prospective cohort study, of
832 adult patients treated in a Norwegian intensive care unit
(ICU) 63% had severe ARF according to the Sequential
Organ Failure Assessment (SOFA; i.e. a ratio of arterial
oxygen tension [PaO2] to fractional inspired oxygen [FiO2]
≤200mmHg [≤26.6kPa] with respiratory support). If no
additional organ failures occurred then the ICU mortality rate
for ARF was 3.2%, and hospital and 90-day mortality rates
were 14.7% and 21.8%, respectively. However, if severe
ARF was accompanied by other organ failures then mortality
increased with each additional organ failure, and was as high
as 75% when five or six organs were in failure.
Incidence figures and mortality rates for
acute respiratory failure
Incidence figures for various forms of ARF have come under
intense scrutiny in recent years because they may allow
assessment of the magnitude of public health consequences,
permit observation of temporal, geographic and demographic
variations, and inform decisions on distribution of hospital
resources. A consensus definition for ARF is not yet
available. However, two European studies, one in 72 ICUs in
Berlin, Germany [2] and the other in 132 ICUs in Sweden,
Denmark and Iceland [3], were conducted that used the
same definition (intubation and mechanical ventilation for
≥24 hours); both employed a multicentre approach and
included large patient cohorts, and both studies were
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Abstract
Recently, incidence ranges for acute respiratory failure (ARF), acute lung injury (ALI) and acute
respiratory distress syndrome (ARDS) in adults were reported and found to be 77.6–88.6, 17.9–34.0,
and 12.6–28.0 cases/100000 population per year, respectively. Mortality rates of approximately 40%
were reported for patients with acute respiratory failure, and similar or slightly lower rates for those with
ALI and ARDS. Some experts believe that there is a trend toward lower mortality rates in ALI and
ARDS, but this suggestion has not been scientifically validated. Additional organ failures, but not
oxygenation indices, appear to be crucial with regard to predicting outcome. Finally, it has remained
uncertain whether there exists seasonal variability with respect to the frequency of various forms of
respiratory failure.
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conducted over 2 months. They found very similar incidences
of ARF, namely 88.6 [2] and 77.6 [3] cases per 100000
population per year. Regarding acute lung injury (ALI) and
acute respiratory distress syndrome (ARDS), several studies
that were conducted all around the world and used the
definitions provided by the American–European Consensus
Conference on ARDS [4] found incidence ranges of
17.9–34.0 and 12.6–28.0 cases per 100000 population per
year, respectively [3,5,6].
Because incidence figures for a whole country or larger
region may not correlate with the number or percentage of
patients actually found in a given ICU, studies that examine
the prevalence of various forms of ARF are helpful in
estimating resource allocation and utilization. Some complex
calculations may be required to determine whether more ARF
patients were treated in one ICU than in another. In this
context, it is difficult to compare the data provided by
Flaatten and coworkers [1] (63% of their cohort of 832 adult
ICU patients had severe ARF, according to their SOFA grade
of 3–4) with, for example, the 1.7% ALI patients and 6.9%
ARDS patients that were recently identified by Roupie and
coworkers [7] in their 14-day prospective cohort study
conducted in 36 French ICUs.
Finally, until now, no epidemiological study has assessed
incidence according to the SOFA criteria for respiratory
failure. However, interesting prevalence data are available
from a study conducted by Pettilä and colleagues [8]. In 520
Finnish ICU patients, evaluated over a 1-year period, 169
(32.5%) fulfilled SOFA criteria for ARF (3 of a maximum
4 points) and/or had additional renal, haematological,
hepatic, circulatory, and neurological organ failures. Nearly
double the percentage (63%) of ARF patients fulfilling the
same criteria were identified by Flaatten and coworkers [1].
This difference is difficult to explain. I speculate that it is
based on a different patient case mix.
Currently, with no consensus definition for ARF available, the
best estimates of ARF mortality rates stem from the Berlin [2]
and Scandinavian [3] studies, namely 42.7% (ICU mortality)
and 41% (90-day mortality), respectively. The hospital
mortality rate for ARF (defined according to SOFA
definitions) in the study conducted by Flaatten and
coworkers [1] for the overall population was 32.9%. In the
Finnish study by Pettilä and coworkers [8], an overall hospital
mortality rate for ARF of 46% was reported. In summary, the
reported mortality rates for ARF are of the same order of
magnitude, although significant differences in study design
and definitions applied are obvious.
Surprisingly, in the 24 patients with isolated pulmonary failure
in the Finnish study [8] the hospital mortality rate was only
17%. Similarly, in the study by Flaatten and colleagues [1]
ICU mortality and hospital discharge mortality rates in
patients with ARF as the only organ failure were 3.2% and
14.7%, respectively. The question arises as to why isolated
respiratory failure leads to such relatively low mortality rates.
Possible explanations are as follows. First, standard
ventilatory treatment strategies are effective in treating
patients with isolated respiratory failure, and other organ
systems that are healthy may be better able to tolerate the
well known adverse effects of mechanical ventilation.
Second, the lung has a marked ability to recover its function.
Finally, it is a well known fact that mortality in the ICU
strongly depends on the presence or absence of multiple
organ dysfunction [9]. Common sense suggests that the
general rule of ‘many organ dysfunctions = bad prognosis’
may be equally valid when rephrased – ‘few organ
dysfunctions = good prognosis’.
Of note, Flaatten and coworkers [1] reported different
mortality rates at different time points. Mortality was lowest on
ICU discharge, it rose on hospital discharge and it reached its
peak when evaluated 90 days after diagnosis of ARF. This
trend was also observed when patients were subgrouped
according to the number of additional organ failures
complicating ARF. These findings underscore the necessity to
continue mortality assessment in clinical studies far beyond
the time of discharge from the ICU. Many examples can be
found in the published literature of studies that suggest that
the risk for dying in the aftermath of ICU treatment for ARF is
not comparable with that in the general population. In a recent
study conducted in 347 patients requiring 14 days or more of
mechanical ventilation [10], of the 208 patients who died
72% did so in the ICU and 28% between the first and 57th
month after ICU discharge. Data from a long-term follow-up
study suggested that mortality associated with ARDS
continues for years after hospital discharge. In this context it
has been calculated that clinical trials that use hospital
mortality as an end-point will capture only 80% of all deaths,
and those that use 100-day mortality will capture 89% [11].
The logical conclusion that should be drawn from these
findings is that the period of observation following hospital
discharge should be extended substantially. Organizational
problems, bureaucratic barriers, and financial restraints,
however, may limit researchers’ ability to follow up patients
several years after survival from an episode of ARF.
For many years experts have discussed the issue of whether
mortality rates in ARDS patients are declining. Since the 1992
American–European Consensus Conference on ARDS, most
clinical series have continued to report a mortality rate of
40–60% in patients with ARDS [12]. There have been several
recent lines of investigation that suggest that mortality from
ARDS at some centres [13–15] may be falling. However, the
broad applicability of these finding is unclear [16].
Multiple organ dysfunctions and severity of
acute respiratory failure
Abnormal organ function may involve the liver, kidneys,
cardiovascular system, brain, blood, and/or the immune290
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system. These organ dysfunctions may be related to the
underlying illness or to the treatment, or they may occur
through the same inflammatory process that injured the
respiratory tract. Apart from the severity of the acute illness,
dysfunctions of vital organs – especially when associated
with severe sepsis or septic shock – and pre-existing
diseases significantly contribute to the observed high
mortality rates in patients with ARF [7,17–19].
The role of the severity of ARF itself is under discussion. It
may depend on the indicator used to assess this severity.
The prognostic value of the PaO2/FiO2 ratio, which is used,
for example, in SOFA, has been subjected to particular
scrutiny. Most authors have not found this variable to be of
prognostic significance [19–21]. In accordance with the
latter findings is that ALI and ARDS, although they are
distinguished by different PaO2/FiO2 cutoff points, have
similar outcomes [3,6]. In this context it is worth mentioning
that, in the recent ARDS Network Trial on low versus
traditional tidal volumes [22], better oxygenation was
observed in patients treated with large tidal volumes during
the acute phase of ALI/ARDS. However, mortality in the latter
group was significantly higher than in those patients treated
with low tidal volumes and a worse PaO2/FiO2. This does not
mean that sufficient oxygenation is an inferior goal of
treatment in ARF patients. Data reported by Hopkins and
associates [23] showed that, in ARDS, there were significant
correlations between the amount of time that arterial oxygen
saturation was below 90%, below 85% and below 80%
during the acute phase of the illness and various cognitive
skills assessed 1 year later. This added to earlier work that
had demonstrated the relation between hypoxic brain injury,
hippocampal atrophy and memory deficit [24].
Chances missed
Until now it has remained uncertain whether there exist
statistically significant differences in the monthly incidences
of adult ARF and ALI. Although common sense dictates that
there are more ARF cases in the winter months, this
assumption has not been scientifically confirmed. The key
underlying problem is that all epidemiological studies on
incidence of ARF were conducted during relatively short time
periods. Therefore, one would have wished that Flaatten and
coworkers [1] had not missed their chance to report on
seasonal variance of occurrence of ARF throughout their
30-month study period. With respect to ARDS, it was
recently shown that no such monthly variation exists [25].
Because the patient population was rather small (n=66) in
that study, confirmation in a larger patient cohort is needed.
Conclusion
The study by Flaatten and coworkers [1] substantially
contributes to our knowledge of ARF epidemiology. It
highlights the crucial role of additional organ failures in the
setting of ARF. The data suggest that rather low mortality rates
can be expected when the patient suffers from isolated
respiratory failure but that these increase exponentially when
additional organ dysfunctions occur. Furthermore, it has again
been shown that there exists ongoing mortality in ARF patients
following their discharge from the ICU. Consequently,
researchers should seek to assess mortality at ICU discharge,
hospital discharge, after 90 days, and ideally after
6–12 months. One would also hope that the issue of seasonal
variability with respect to the frequency of various forms of ARF
will be addressed by systematic studies in the near future.
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